Radar · Life Sciences in Bengaluru
Best Life Sciences Companies in Bengaluru, India
The 392 best Life Sciences companies in Bengaluru, India in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: MedGenome.
By Riya SenguptaFinancials
392companies tracked
$897.1Mdisclosed funding
0unicorns
150have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × BENGALURU
Our analysis of 50 Life Sciences companies
$1.2b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.
50companies analysed
77%cloud-native stacks
2024funding peak (by rounds)
2018median founding year
52median Fliar Index™
899kcombined LinkedIn audience
49%of audience held by top 3
11companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Bengaluru
| # | Company | Disclosed funding | Revenue | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | MedGenome Provider of DNA sequencing, bioinformatics, and multiomics services 83Funding top 20%Fin. health top 21%Moat top 22%Market top 25% All 10 signals ▾Fundingtop 20% Fin. healthtop 21% Moattop 22% Markettop 25% Talenttop 28% Techtop 32% Producttop 36% Growthtop 50% Globalbottom 45% Newsbottom 40% Funding: Raised $217M across 10 rounds · 10 rounds over 13 yrs (0.8/yr) Fin. health: Revenue ~$48.1M (FY2024) · Net margin 17.5% rank vs industry peers · Fliar Intelligence Index 83/100 | $217M | $48M FY2025 | 883 883 → 1,006 (+14%) · sector median +49% | 2013 | Mahesh Pratapneni Co-Founder & Group CEO | — | 1 job opening |
| 2 | Kapiva Provider of ayurvedic healthcare and nutritional products to improve health 87Market top 20%Moat top 20%News top 21%Funding top 24% All 10 signals ▾Markettop 20% Moattop 20% Newstop 21% Fundingtop 24% Growthtop 26% Talenttop 28% Techtop 30% Producttop 36% Fin. healthtop 41% Globalbottom 37% Market: 376 employees (top 4% of Life Sciences) · Revenue ~$41.3M Moat: Top 1% by revenue among 243 tracked Nutraceuticals Tech companies · Editorial + unicorn rating 8/10 rank vs industry peers · Fliar Intelligence Index 87/100 | $51M | $41M FY2025 | 376 376 → 526 (+40%) · sector median +49% | 2016 | Shantanu Co-Founder | — | 1 expansion |
| 3 | Strand Life Sciences Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $37M | $14M FY2025 | 522 | 2000 | Viswanathan Vinay Co-Founder | 9 patents Predictive cancer drug response testing and metabolomics-based liver toxicity diagnostics | 3 job openings |
| 4 | Futura Surgicare Manufacturer of wound closure products and sterile sutures 60Moat top 22%Market top 30%Funding top 43%Fin. health top 43% All 7 signals ▾Moattop 22% Markettop 30% Fundingtop 43% Fin. healthtop 43% Growthtop 48% Globalbottom 32% Newsbottom 21% Moat: Top 17% by revenue among 23 tracked Surgical Instruments companies · Editorial + unicorn rating 7/10 Market: 381 employees (top 3% of Life Sciences) · Revenue ~$10.6M rank vs industry peers · Fliar Intelligence Index 60/100 | $25M | $11M FY2025 | 381 | 1994 | — | — | — |
| 5 | Remidio Developer of AI-powered portable digital solutions for ophthalmic screening and diagnosis | $25M | $7M FY2025 | 153 153 → 228 (+49%) · sector median +49% | 2009 | Anand Sivaraman Co-Founder & Chief Executive Officer | — | 1 launch |
| 6 | Forus Health Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms 69Innovation top 25%Moat top 27%Patents top 31%Product top 32% All 12 signals ▾Innovationtop 25% Moattop 27% Patentstop 31% Producttop 32% Fundingtop 33% Newstop 36% Talenttop 38% Markettop 40% Fin. healthtop 40% Growthtop 42% Globalbottom 44% Techbottom 43% Innovation: 41 patents (top 30% of patent-holders) · 14 filings since 2022 vs 9 in 2017-21 Moat: Top 19% by revenue among 27 tracked Ophthalmology companies · Editorial + unicorn rating 7/10 rank vs industry peers · Fliar Intelligence Index 69/100 | $18M | $6M FY2025 | 121 | 2010 | Shyam Vasudevarao Co-Founder & Director | 37 patents Portable retinal imaging systems with annular illumination for neonatal and clinical eye diagnostics | 1 launch |
| 7 | InnAccel Developer of medical devices for critical care, obstetrics, and neonatology | $6M | $4M FY2025 | 45 45 → 84 (+87%) · sector median +49% | 2012 | Vibhav Joshi Co-Founder & Director | — | 1 award |
| 8 | HRS Navigation Manufacturer of surgical navigation systems for cranial, spinal, and ENT surgeries 67Innovation top 23%Growth top 31%Tech top 38%Moat top 38% All 10 signals ▾Innovationtop 23% Growthtop 31% Techtop 38% Moattop 38% Talenttop 38% Producttop 43% Fin. healthtop 47% Markettop 48% Fundingbottom 47% Globalbottom 32% Innovation: 9 product lines · Deep-tech classification: Tech Hardware Growth: Headcount 64 → 89 (+39%) across vintages · Revenue +37% YoY rank vs industry peers · Fliar Intelligence Index 67/100 | $8M | $3M FY2025 | 89 89 → 102 (+15%) · sector median +49% | 2015 | Arpit Paliwal Co-Founder & CEO & Director | — | 1 job opening · 1 launch |
| 9 | Bugworks Research Developer of drugs for antibiotic-resistant bacterial infections and cancer | $43M | $3M FY2025 | 31 31 → 47 (+52%) · sector median +49% | 2014 | Bala Subramanian Co-Founder & COO | — | — |
| 10 | Velbiom Probiotics Provider of probiotic supplements for multiple ailments | $5M | $3M FY2025 | 197 | 2015 | Saikat Ray Chief Executive Officer | — | — |
| 11 | Stempeutics Stem-cell-based products for osteoarthritis and buerger's disease | $47M | $2M FY2025 | 30 | 2006 | — | — | — |
| 12 | Morphle Provider of robotic microtomes and digital pathology scanners. 67Growth top 31%Tech top 33%Moat top 36%AI top 45% All 9 signals ▾Growthtop 31% Techtop 33% Moattop 36% AItop 45% Markettop 47% Fundingtop 47% Fin. healthtop 49% Talentbottom 49% Globalbottom 43% Growth: Headcount 43 → 52 (+21%) across vintages · Revenue +25% YoY Tech: 36 technologies across 6/8 capability areas · Cloud: Amazon S3, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 67/100 | $150K | $2M FY2025 | 52 52 → 100 (+92%) · sector median +49% | 2017 | Rohit Hiwale Co-Founder & CEO | — | — |
| 13 | Decode Age Online retailer of longevity supplements and provider of microbiome tests 60Tech top 24%Growth top 27%Talent top 28%Innovation top 33% All 10 signals ▾Techtop 24% Growthtop 27% Talenttop 28% Innovationtop 33% Moattop 37% Producttop 43% Fundingbottom 46% Marketbottom 39% Fin. healthbottom 39% Globalbottom 37% Tech: 51 technologies across 5/8 capability areas · Cloud: Akamai, Amazon Ses Growth: Revenue +26% YoY · Web rank 1,000,000 → 500,000 YoY rank vs industry peers · Fliar Intelligence Index 60/100 | $274K | $2M FY2025 | 8 | 2021 | Rakesh Somani Co-Founder & COO | — | — |
| 14 | 4baseCare Provider of precision oncology solutions, including genomic testing and digital health 50Moat top 33%Innovation top 34%Funding top 35%Product top 36% All 11 signals ▾Moattop 33% Innovationtop 34% Fundingtop 35% Producttop 36% Talenttop 38% Techtop 43% Globalbottom 49% Growthbottom 47% Newsbottom 44% Marketbottom 43% Fin. healthbottom 37% Moat: Top 15% by revenue among 130 tracked Genomics companies · Editorial + unicorn rating 5/10 Innovation: 12 product lines rank vs industry peers · Fliar Intelligence Index 50/100 | $8M | $2M FY2025 | 25 | 2018 | Hitesh Goswami Co-Founder & CEO | — | — |
| 15 | Supply6 Online retailer of nutritional supplements including protein powders and wafers | $987K | $1M FY2025 | 3 | 2019 | Rahul Jacob Co-Founder & COO | — | 1 launch |
| 16 | Immuneel Developer of T-cell therapies for the treatment of cancer 40Moat top 31%Funding top 40%Growth top 46%Market top 49% All 9 signals ▾Moattop 31% Fundingtop 40% Growthtop 46% Markettop 49% Talentbottom 49% Fin. healthbottom 44% Globalbottom 39% Techbottom 31% Newsbottom 18% Moat: Top 21% by revenue among 34 tracked Oncology companies · Editorial + unicorn rating 7/10 Funding: Raised $39.3M across 4 rounds · 4 rounds over 7 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $39M | $1M FY2025 | 67 67 → 112 (+67%) · sector median +49% | 2018 | Siddhartha Mukherjee Co-Founder | — | — |
| 17 | SigTuple Provider of AI-powered diagnostic solutions for laboratories and hospitals 72Moat top 23%Funding top 25%AI top 26%Talent top 28% All 10 signals ▾Moattop 23% Fundingtop 25% AItop 26% Talenttop 28% Growthtop 36% Techtop 38% Markettop 47% Fin. healthbottom 44% Globalbottom 39% Newsbottom 21% Moat: Top 9% by revenue among 46 tracked Computer Vision companies · Editorial + unicorn rating 8/10 Funding: Raised $54.7M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 72/100 | $55M | $1M FY2025 | 95 95 → 101 (+6%) · sector median +49% | 2015 | Pranat Bhadani Co-Founder & Business Head | — | 1 award |
| 18 | Cardiotrack Provider of AI-driven platform for preventive and insurance policy-based medical screenings | $4M | $817K FY2022 | 305 | 2014 | Avin Agarwal ex-Co-Founder & CEO | — | 2 launchs |
| 19 | Caltech Innovations Developer of device of pulmonary function test | $580K | $793K FY2025 | 36 | 2016 | Jayavanth Kamath Founder & CEO | — | — |
| 20 | GangaGen Develop drugs for the prevention and treatment of bacterial infections that are resistant to antibiotics 27Product top 36%Moat top 39%Growth top 46%Funding top 47% All 11 signals ▾Producttop 36% Moattop 39% Growthtop 46% Fundingtop 47% Talentbottom 49% Globalbottom 47% Fin. healthbottom 42% Marketbottom 40% Patentsbottom 38% Innovationbottom 34% Techbottom 30% Product: 2 distinct product lines · Company stage: Acquired Moat: Top 40% by revenue among 42 tracked Infectious Diseases companies · Editorial + unicorn rating 5/10 rank vs industry peers · Fliar Intelligence Index 27/100 | $13M | $712K FY2022 | 37 37 → 68 (+84%) · sector median +49% | 2000 | Janakiraman Ramachandran Chairman & CEO | 16 patents Phage‑based antimicrobial therapeutics and engineered antibacterial peptides for bacterial infections | — |
| 21 | Leucine Rich Bio Provider of the genomics-based platform to analyze microbiome | $425K | $662K FY2025 | 13 | 2014 | Drdebojyoti Dhar Co-Founder and Director (Business Development and Innovation) | — | — |
| 22 | FibroHeal Developer of silk proteins as biomaterials for wound healing | $2M | $618K FY2025 | 36 36 → 64 (+78%) · sector median +49% | 2017 | Subramanian Shivaraman Co-Founder & Director | — | 1 launch |
| 23 | Janitri Developer of fetal, maternal, and newborn health monitoring solutions 42Tech top 34%Moat top 37%Growth top 40%Funding top 46% All 9 signals ▾Techtop 34% Moattop 37% Growthtop 40% Fundingtop 46% Talentbottom 49% Marketbottom 45% Productbottom 45% Globalbottom 39% Fin. healthbottom 27% Tech: 35 technologies across 5/8 capability areas · Cloud: Cloudflare Moat: Top 23% by revenue among 830 tracked Healthcare IT companies · Editorial + unicorn rating 5/10 rank vs industry peers · Fliar Intelligence Index 42/100 | $2M | $609K FY2025 | 46 | 2016 | Arun Agarwal Founder & CEO | — | — |
| 24 | Jananom Developer of bio-ingredients through precision fermentation and metabolic engineering processes | $2M | $576K FY2025 | — | 2018 | Chitra Murali Co-Founder | — | — |
| 25 | Voxelgrids Provider of next-generation magnetic resonance imaging scanners for clinical diagnosis | $7M | $565K FY2025 | 32 32 → 19 (-41%) · sector median +49% | 2017 | Arjun Arunachalam Founder & CEO | — | — |
| 26 | Mojocare Digital platform providing customized solutions for wellness | $24M | $563K FY2025 | 3 | 2020 | Rajat Gupta Co-Founder | — | — |
| 27 | Zumutor Developer of novel immunotherapy and monoclonal antibody therapeutics 22Innovation top 34%Product top 36%Funding top 42%Tech top 50% All 10 signals ▾Innovationtop 34% Producttop 36% Fundingtop 42% Techtop 50% Globalbottom 43% Moatbottom 40% Growthbottom 33% Marketbottom 29% Newsbottom 27% Fin. healthbottom 16% Innovation: 4 product lines Product: 4 distinct product lines · Company stage: Series A rank vs industry peers · Fliar Intelligence Index 22/100 | $26M | $547K FY2025 | 24 24 → 25 (+4%) · sector median +49% | 2013 | — | — | — |
| 28 | Ayati Devices Developer of medical devices for diabetic neuropathy screening. | $623K | $507K FY2025 | — | 2019 | Nishant Kathpal Co-Founder & CEO | — | 1 launch |
| 29 | Mynvax Developer of novel recombinant vaccines to fight the human influenza virus and COVID19 | $10M | $421K FY2025 | 29 | 2017 | — | 10 patents Design of recombinant viral protein fragment vaccines targeting influenza and SARS‑CoV‑2 antigens | — |
| 30 | Pandorum Developer of regenerative medicine and 3D tissues 50News top 28%Funding top 30%Growth top 32%Moat top 36% All 9 signals ▾Newstop 28% Fundingtop 30% Growthtop 32% Moattop 36% Talenttop 38% Techbottom 47% Fin. healthbottom 45% Globalbottom 44% Marketbottom 40% News: 4 BI events in 12 mo (of 17 tracked, 1 types) · Top themes: Funding Funding: Raised $27.1M across 10 rounds · 10 rounds over 11 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 50/100 | $27M | $417K FY2025 | 26 26 → 44 (+69%) · sector median +49% | 2011 | Tuhin Bhowmick Co-Founder & CEO & Director | — | — |
| 31 | Nexstem AI-powered wearable device for electrodiagnostic testing 27Moat top 43%AI top 45%Talent top 45%Funding top 47% All 9 signals ▾Moattop 43% AItop 45% Talenttop 45% Fundingtop 47% Techbottom 48% Globalbottom 36% Fin. healthbottom 32% Marketbottom 30% Newsbottom 18% Moat: Top 42% by revenue among 12 tracked Neurology companies · Editorial + unicorn rating 5/10 AI: Product described with: ai-powered rank vs industry peers · Fliar Intelligence Index 27/100 | $5M | $378K FY2023 | 10 | 2020 | Siddhant Dangi Co-Founder & CEO | — | — |
| 32 | Eyestem Developer of cell replacement therapies to treat ophthamological conditions 22Talent top 28%Product top 40%Innovation top 43%Funding top 43% All 11 signals ▾Talenttop 28% Producttop 40% Innovationtop 43% Fundingtop 43% Growthbottom 46% Moatbottom 43% Globalbottom 37% Techbottom 27% Newsbottom 27% Marketbottom 25% Fin. healthbottom 14% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Product: 2 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 22/100 | $10M | $252K FY2025 | 1 | 2015 | Rajarshi Pal Co-Founder | — | 1 job opening · 2 awards |
| 33 | Peptris Provider of AI-based proteomic data analysis software for drug discovery 69Growth top 18%AI top 23%Talent top 28%News top 38% All 10 signals ▾Growthtop 18% AItop 23% Talenttop 28% Newstop 38% Fin. healthtop 42% Fundingtop 43% Moattop 50% Techbottom 47% Marketbottom 38% Globalbottom 37% Growth: Revenue +305% YoY · Fresh capital in last 24 mo AI: Classified as an agentic-AI company · Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 69/100 | $1M | $228K FY2025 | — | 2019 | Narayanan Venkatasubramanian Co-Founder & CEO | — | 2 job openings |
| 34 | Medevplus Developer of portable, affordable deep-tech medical devices utilizing optics and photonics technology for… | $80K | $203K FY2025 | 18 | 2018 | Sweta Patnaik Co-Founder & Director of Finance | — | 2 internships |
| 35 | Algorithmic Biologics Provider of software solutions for molecular diagnostics and discovery | $3M | $193K FY2025 | 12 | 2021 | Manoj Gopalkrishnan Founder & CEO | 20 patents Multiplexed nucleic‑acid quantification via molecular sum‑gate assays reducing test counts | — |
| 36 | IntEssence Manufacture of dental implants | $127K | $163K FY2025 | — | 2015 | Hariprasad Rao Founder & Director | — | — |
| 37 | AltLife Health and wellness platform that focuses on using food as medicine 32Tech top 33%Innovation top 34%Product top 48%Funding bottom 49% All 10 signals ▾Techtop 33% Innovationtop 34% Producttop 48% Fundingbottom 49% Talentbottom 49% Growthbottom 41% Moatbottom 41% Marketbottom 36% Globalbottom 30% Fin. healthbottom 19% Tech: 68 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare Innovation: 4 product lines rank vs industry peers · Fliar Intelligence Index 32/100 | $5M | $152K FY2025 | 51 51 → 54 (+6%) · sector median +49% | 2018 | Vivek Subramaniyam Founder & CEO | — | 1 launch |
| 38 | Mestastop Developer of cell-based functional assays for cancer metastasis focused drug discovery and predictive… 50Growth top 20%Patents top 35%Talent top 38%Tech top 43% All 11 signals ▾Growthtop 20% Patentstop 35% Talenttop 38% Techtop 43% Innovationtop 45% Moattop 47% Fundingtop 48% Fin. healthbottom 44% Globalbottom 40% Marketbottom 27% Newsbottom 22% Growth: Revenue +743% YoY · Fresh capital in last 24 mo Patents: 9 patents matched (strict assignee match) · 9 filings since 2022 vs 0 in 2017-21 rank vs industry peers · Fliar Intelligence Index 50/100 | $1M | $134K FY2025 | 12 | 2018 | Debabani Chowdhury Co-Founder | 8 patents AI-driven cancer metastasis prediction and drug screening platforms | — |
| 39 | Cureous Developer of AI‑enabled patient engagement and care coordination platform | $456K | $88K FY2024 | — | 2020 | Asish Mohandas Founder & CEO | — | — |
| 40 | Lumov Health Manufacturer of orthopedic braces and rehabilitation aids for pain management | $1M | $48K FY2025 | — | 2024 | Ankit Gupta Co-Founder | — | — |
| 41 | Biopeak Provider of personalized health programs integrating diagnostics and multidisciplinary expertise 29Growth top 28%Talent top 38%Tech top 41%Funding top 49% All 8 signals ▾Growthtop 28% Talenttop 38% Techtop 41% Fundingtop 49% Moatbottom 37% Globalbottom 32% Marketbottom 24% Fin. healthbottom 12% Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 29/100 | $11M | $47K FY2025 | — | 2024 | Shiva Subramanian Co-Founder & CTO | — | 1 job opening · 1 internship |
| 42 | Ykrita Life Sciences Developer of a bioengineered artificial ectopic liver device 6Talent top 35%Funding bottom 43%Growth bottom 32%Global bottom 29% All 6 signals ▾Talenttop 35% Fundingbottom 43% Growthbottom 32% Globalbottom 29% Marketbottom 9% Fin. healthbottom 5% Talent: 3 named leaders on record Funding: Raised $1.9M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 6/100 | $2M | $22K FY2025 | — | 2020 | Mahesh Gopasetty Co-Founder | — | — |
| 43 | BioDimension Developer of advanced human tissue models and patient-derived organoids for pharmaceutical research | $144K | $10K FY2025 | — | 2021 | Manoj Sampath Co-Founder & CEO | — | 1 launch |
| 44 | immunitoAI Developer of AI-based platform for antibody discovery and therapeutics 16AI top 30%Funding top 38%Talent top 38%Growth bottom 43% All 9 signals ▾AItop 30% Fundingtop 38% Talenttop 38% Growthbottom 43% Globalbottom 37% Moatbottom 30% Marketbottom 22% Techbottom 22% Fin. healthbottom 13% AI: Classified as an AI company · Product described with: ai-based Funding: Raised $1.0M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 16/100 | $1M | $7K FY2025 | 22 22 → 25 (+14%) · sector median +49% | 2020 | Trisha Chatterjee Co-Founder & CTO | — | — |
| 45 | The Stack Retailer of supplements formulated for sleep, gut health, and immunity 22Growth top 20%Talent top 38%Tech top 48%Funding bottom 42% All 7 signals ▾Growthtop 20% Talenttop 38% Techtop 48% Fundingbottom 42% Globalbottom 36% Marketbottom 16% Fin. healthbottom 7% Growth: Web rank 10,000,000 → 1,000,000 YoY · Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 22/100 | $608K | $6K FY2025 | — | 2024 | Kshitij Rihal Co-Founder | — | 2 job openings |
| 46 | Lemnisca Developer of AI software for fermentation‑based production of biomolecules 45Talent top 45%Global bottom 48%Funding bottom 45%Tech bottom 44% All 4 signals ▾Talenttop 45% Globalbottom 48% Fundingbottom 45% Techbottom 44% Talent: 2 named leaders on record Global: Investors from 1 country beyond India rank vs industry peers · Fliar Intelligence Index 45/100 | $837K | — | — | 2025 | Shilpa Nargund Co-Founder & CTO | — | — |
| 47 | bioLOCKEY Healthworks Developer of point-of-care diagnostics and novel biologics by Nanobody discovery platform 16Funding top 43%Talent top 45%Tech bottom 43%Global bottom 36% All 5 signals ▾Fundingtop 43% Talenttop 45% Techbottom 43% Globalbottom 36% Marketbottom 13% Funding: Raised $143k across 5 rounds · 5 rounds over 3 yrs (1.7/yr) Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 16/100 | $143K | — | — | 2023 | Minhaj Sirajuddin Co-Founder & Director | — | — |
| 48 | Cambrian Bioworks Manufacturer of PCR plate seal, sample preparation, and extraction kits | $1M | — | 30 30 → 50 (+67%) · sector median +49% | 2020 | Rohit Asil Co-Founder | — | 1 partnership |
| 49 | Eurofins Genomics Provider of genomics products and service in sequencing | $3M | — | 453 | 1990 | Gilles Martin CEO | — | 1 partnership |
| 50 | Connexios Life Sciences Targeted small molecule drugs for metabolic diseases | $34M | — | — | 2003 | Sriram Nadathur Director | 104 patents Novel small‑molecule therapeutics for wound healing, RXR and GPR40 receptor modulation | — |
Top 12 Life Sciences companies in Bengaluru
#1
Series B · Bengaluru, Karnataka · founded 2011 · 26 employees$27.1Mraised▾
Series B · Bengaluru, Karnataka · founded 2011 · 26 employees
Developer of regenerative medicine and 3D tissues. It has developed a working 3D tissue through 3D printing and fabrication techniques. The products include bioengineered cornea which is a hydrogel formulation used for blindness, 3D hepatocyte spheroids for drug discovery and liver therapies, and exosome cell-free therapy for lung regeneration.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
News
top 28%Funding
top 30%Growth
top 32%Moat
top 36%Talent
top 38%Tech
bottom 47%News: 4 BI events in 12 mo (of 17 tracked, 1 types) · Top themes: Funding
Funding: Raised $27.1M across 10 rounds · 10 rounds over 11 yrs (0.9/yr) · Last round Series B (Mar 2026)
Growth: Headcount 27 → 26 (-4%) across vintages · Revenue +322% YoY · Fresh capital in last 24 mo
Audience (LinkedIn): 17k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Masters in Bioinformatics, Computational Biology
Funding rounds
- Mar 2026Series B$429.4K
- Oct 2025Series B$18M
- Jan 2024Series A$2M
- Aug 2023Series A$11M
Founders & team
Investors
KITVEN, 500 Global, BFL Investments and Financial Consultants, Clarion Technologies, Golcha Fingrowth, Apollo Trading Company
Tech stack
CloudflareCloudflare Browser InsightsContact Form 7CookieyesCore-JsElementor
#2
Series E · Bengaluru, Karnataka · founded 2013 · 883 employees$217Mraised▾
Series E · Bengaluru, Karnataka · founded 2013 · 883 employees
Provider of DNA sequencing, bioinformatics, and multiomics services. It offers a comprehensive suite of genomic services which include whole genome and exome sequencing, single-cell sequencing, spatial transcriptomics, and immune profiling. It also provides robust bioinformatics support, including analysis pipelines and data visualization tools, to facilitate research and drug discovery. The services are tailored to support research in various areas, including rare disease research, cancer research, and antibody discovery.
Fliar Intelligence Index™ 83how this company ranks against its industry peers
Funding
top 20%Fin. health
top 21%Moat
top 22%Market
top 25%Talent
top 28%Tech
top 32%Funding: Raised $217M across 10 rounds · 10 rounds over 13 yrs (0.8/yr) · Last round Series E (Jul 2025)
Fin. health: Revenue ~$48.1M (FY2024) · Net margin 17.5%
Moat: Top 6% by revenue among 118 tracked Clinical Laboratory Chains companies · Editorial + unicorn rating 8/10 · Soonicorn
Audience (LinkedIn): 135k LinkedIn followers — 15.1% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Business Development Manager (Pathology Sales)
Funding rounds
- Jul 2025Series E$47.5M
- Aug 2022Series D$50M
- Jul 2021Series D$16.5M
- Apr 2020Series D$55M
Founders & team
Investors
Europa, LeapFrog Investments, Sofina, Peak XV Partners, IFC, Kemwel
Tech stack
All In One SeoApache Http ServerBootstrapCloudflareCloudflare Bot ManagementComplianz
#3
Series D · Bengaluru, Karnataka · founded 2016 · 376 employees$50.5Mraised▾
Series D · Bengaluru, Karnataka · founded 2016 · 376 employees
Provider of ayurvedic healthcare and nutritional products to improve health. It offers a diverse portfolio of ayurvedic products, including ayurvedic juices, herbal capsules, gummies, powdered drinks, plant based proteins, cooking oils, hair, skin, and body oils. The products helps improve heart health, blood sugar and chronic care, weight management, skin care, and daily wellness products.
Fliar Intelligence Index™ 87how this company ranks against its industry peers
Market
top 20%Moat
top 20%News
top 21%Funding
top 24%Growth
top 26%Talent
top 28%Market: 376 employees (top 4% of Life Sciences) · Revenue ~$41.3M · ~4% of tracked Nutraceuticals Tech revenue (243 cos, FY2025)
Moat: Top 1% by revenue among 243 tracked Nutraceuticals Tech companies · Editorial + unicorn rating 8/10 · Soonicorn
News: 9 BI events in 12 mo (of 36 tracked, 7 types) · +80% YoY · 5 high-value events (IPO/M&A/funding/contracts) in 12 mo
Audience (LinkedIn): 192k LinkedIn followers — 21.4% of this cohort's audience
Activity (LinkedIn): 1 expansions announced in 12 mo
Funding rounds
- Sep 2025Series D$28M
- Sep 2024Series C$10M
- Feb 2024Angel$106.9K
- Sep 2023Series B$11.8M
Founders & team
Investors
Jetty Ventures, Goodcare Pharma, Fireside Ventures, New Age Enclave, Brahaspati Merchandise, Nprgroup
Tech stack
Cart FunctionalityCloudflareCloudflare Bot ManagementCloudflare Browser InsightsCore-JsFacebook Pixel
#4
Series B · Bengaluru, Karnataka · founded 2018 · 25 employees$8.1Mraised▾
Series B · Bengaluru, Karnataka · founded 2018 · 25 employees
Provider of precision oncology solutions, including genomic testing and digital health. It uses AI, cancer genomics, and real-world clinical data to personalize cancer treatment. It builds tools and lab solutions that help doctors and researchers understand a patients cancer at the genetic level and choose better treatments. The company provides comprehensive genome profiling to identify biomarkers for therapy resistance.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Moat
top 33%Innovation
top 34%Funding
top 35%Product
top 36%Talent
top 38%Tech
top 43%Moat: Top 15% by revenue among 130 tracked Genomics companies · Editorial + unicorn rating 5/10 · 9 curated direct competitors tracked
Innovation: 12 product lines
Funding: Raised $8.1M across 7 rounds · 7 rounds over 8 yrs (0.9/yr) · Last round Series B (Jan 2026)
Audience (LinkedIn): 40k LinkedIn followers — 4.4% of this cohort's audience
Funding rounds
- Jan 2026Series B$9.8M
- Nov 2025Series A$991.4K
- Dec 2024Series A$3.4M
- Jul 2024Series A$6M
Founders & team
Investors
Mount Judi Ventures, Season Two Ventures, First In Ventures, growX Ventures Fund, BIRAC, Startup Karnataka
Tech stack
CloudflareGoogle AnalyticsGoogle Font ApiGoogle Hosted LibrariesGoogle Tag ManagerGoogle Workspace
#5
Series B · Bengaluru, Karnataka · founded 2010 · 121 employees$18.1Mraised▾
Series B · Bengaluru, Karnataka · founded 2010 · 121 employees
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms. These devices are designed for acquiring, storing, and transmitting images of the eye's anterior and posterior segments, facilitating the diagnosis of various ocular diseases. The cloud-based platform integrates with the imaging devices, enabling remote diagnosis and efficient monitoring of patients. The company's technology aims to improve access to eye care, particularly in underserved areas. The devices are designed for ease of use and affordability, making them suitable for a wide range of healthcare settings.
Fliar Intelligence Index™ 69how this company ranks against its industry peers
Innovation
top 25%Moat
top 27%Patents
top 31%Product
top 32%Funding
top 33%News
top 36%Innovation: 41 patents (top 30% of patent-holders) · 14 filings since 2022 vs 9 in 2017-21 · 12 product lines
Moat: Top 19% by revenue among 27 tracked Ophthalmology companies · Editorial + unicorn rating 7/10 · IP moat: 41 patents
Patents: 41 patents matched (strict assignee match) · 14 filings since 2022 vs 9 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 11k LinkedIn followers
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Nov 2025Series B—
- Jan 2020Series B$1.9M
- Oct 2018Series B$2.5M
- Mar 2018Series B$508K
Founders & team
Investors
Asian Healthcare Fund, Accel, TEAMFund, Chiratae Ventures, IIMA Ventures, TeamFund App
Tech stack
Apache Http ServerBootstrapCdnjsCloudflareComplianzContact Form 7
#6
Series A · Bengaluru, Karnataka · founded 2024$11Mraised▾
Series A · Bengaluru, Karnataka · founded 2024
Provider of personalized health programs integrating diagnostics and multidisciplinary expertise. The organization delivers advanced diagnostic services, personalized protocols, and multidisciplinary teams to optimize health. It uses a proprietary system to bring together science and personalized care. The company offers health strategies for individuals with health concerns, peak performers, and active health seekers. It analyzes health at cellular, tissue, organ, and system levels.
Fliar Intelligence Index™ 29how this company ranks against its industry peers
Growth
top 28%Talent
top 38%Tech
top 41%Funding
top 49%Moat
bottom 37%Global
bottom 32%Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Tech: 26 technologies across 4/8 capability areas · Cloud: Cloudflare · Security: Cloudflare Bot Management, Hsts
Audience (LinkedIn): 5k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public)
Funding rounds
- Dec 2025Series A$3M
- Oct 2025Series A$880.9K
- Jul 2025Series A$3.5M
- May 2025Seed$1.2M
Founders & team
Investors
Claypond Capital, Manipal Group, Saral Group, NK Squared, Rainmatter, Accel
Tech stack
CloudflareCloudflare Bot ManagementCore-JsFacebook PixelFramer SitesGodaddy
#7
Seed · Bengaluru, Karnataka · founded 2015 · 89 employees$7.6Mraised▾
Seed · Bengaluru, Karnataka · founded 2015 · 89 employees
Manufacturer of surgical navigation systems for cranial, spinal, and ENT surgeries. The company provides surgical system platforms designed to meet specific surgical requirements. Its software suite supports cranial, spinal, and ENT procedures. The systems offer tools intended to optimize procedural outcomes.
Fliar Intelligence Index™ 67how this company ranks against its industry peers
Innovation
top 23%Growth
top 31%Tech
top 38%Moat
top 38%Talent
top 38%Product
top 43%Innovation: 9 product lines · Deep-tech classification: Tech Hardware
Growth: Headcount 64 → 89 (+39%) across vintages · Revenue +37% YoY · Fresh capital in last 24 mo
Tech: 43 technologies across 4/8 capability areas · Cloud: Cloudflare · Observability: Microsoft Clarity
Audience (LinkedIn): 15k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Lead Developer (C++/Qt)
Activity (LinkedIn): 1 product launches announced in 12 mo
Funding rounds
- Nov 2025Seed$5M
- May 2022Seed$2.6M
- Aug 2017Grant (prize money)—
Founders & team
Investors
Startup Karnataka, Pro India Capital Multipliers, Gujarat Venture Finance, Physis Capital, Sathguru Catalysers, Exim Bank
Tech stack
Apache Http ServerCloudflareCloudflare Bot ManagementCloudflare Browser InsightsContact Form 7Core-Js
#8
Series B · Bengaluru, Karnataka · founded 2015 · 1 employees$9.9Mraised▾
Series B · Bengaluru, Karnataka · founded 2015 · 1 employees
Developer of cell replacement therapies to treat ophthamological conditions. The company's product line include Eyecyte-RPE is a suspension of retinal pigment epithelium cells derived from human induced pluripotent stem cells. The therapy aims to replace damaged RPE cells in the retina, which are critical in Dry AMD, potentially arresting and reversing vision loss.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Talent
top 28%Product
top 40%Innovation
top 43%Funding
top 43%Growth
bottom 46%Moat
bottom 43%Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Product: 2 distinct product lines · Company stage: Series B
Innovation: 2 product lines
Audience (LinkedIn): 6k LinkedIn followers
Hiring (LinkedIn): 2 hiring posts in 12 mo (public) · momentum +0 · hiring: Equipment & Instrumentation Specialist – Cell Therapy, Quality Control (QC) Analyst – Stem Cell Therapy
Activity (LinkedIn): 2 awards announced in 12 mo
Funding rounds
- Aug 2025Series B$10M
- Aug 2022Series A$6.4M
- May 2021Seed$479.2K
- Oct 2020Seed$1.2M
Founders & team
Investors
Biological E, Alkem Laboratories, Natco Pharma, Endiya Partners, Innovative Quest, Fastspeed Vanijya
Tech stack
All In One SeoApache Http ServerBootstrapContact Form 7Font AwesomeGodaddy
#9
Series C · Bengaluru, Karnataka · founded 2015 · 95 employees$54.7Mraised▾
Series C · Bengaluru, Karnataka · founded 2015 · 95 employees
Provider of AI-powered diagnostic solutions for laboratories and hospitals. It is a healthcare technology company that leverages artificial intelligence, robotics, and cloud computing to develop intelligent screening solutions for medical diagnostics. The products are designed to automate microscopy and enable AI-assisted digital analysis of visual medical data.
Fliar Intelligence Index™ 72how this company ranks against its industry peers
Moat
top 23%Funding
top 25%AI
top 26%Talent
top 28%Growth
top 36%Tech
top 38%Moat: Top 9% by revenue among 46 tracked Computer Vision companies · Editorial + unicorn rating 8/10 · Soonicorn
Funding: Raised $54.7M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) · Last round Series C (Aug 2024)
AI: Classified as an AI company · Product described with: ai-powered, artificial intelligence
Audience (LinkedIn): 32k LinkedIn followers — 3.6% of this cohort's audience
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Aug 2024Series C$3.9M
- Jan 2023Series C$4.8M
- Dec 2021Series C$1.4M
- Apr 2019Series C$19M
Founders & team
Investors
Endiya Partners, Trusted Insight, Axilor Ventures, Accel, NetApp Excellerator, Chiratae Ventures
Tech stack
AceAngularBootstrapCdnjsCloudflareCore-Js
#10
Series A · Bengaluru, Karnataka · founded 2013 · 24 employees$26.2Mraised▾
Series A · Bengaluru, Karnataka · founded 2013 · 24 employees
Developer of novel immunotherapy and monoclonal antibody therapeutics. This company utilizes a proprietary human antibody platform to identify and develop first-in-class therapeutic antibodies. These antibodies target innate immunity and modulate the tumor microenvironment, focusing on targeted NK cell therapeutics within the immuno-oncology field. The company's approach centers on a platform for developing improved monoclonal antibody therapeutics. They maintain a commitment to scientific talent development within therapeutic research and development.
Fliar Intelligence Index™ 22how this company ranks against its industry peers
Innovation
top 34%Product
top 36%Funding
top 42%Tech
top 50%Global
bottom 43%Moat
bottom 40%Innovation: 4 product lines
Product: 4 distinct product lines · Company stage: Series A
Funding: Raised $26.2M across 8 rounds · 8 rounds over 13 yrs (0.6/yr) · Last round Series A (Nov 2024)
Audience (LinkedIn): 9k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. MAHE) announced in 12 mo
Funding rounds
- Nov 2024Series A$730.4K
- Feb 2024Series A$720.3K
- Oct 2022Series A$241.3K
- Aug 2021Series A$6.2M
Investors
Accel, Aarin Capital, IDG Ventures, Karnataka Information Technology Venture Capital Fund, Bharat Innovation Fund, Siana Capital
Tech stack
BootstrapChart.JsCloudflareCloudflare Browser InsightsContact Form 7Core-Js
#11
Series A · Bengaluru, Karnataka · founded 2019$1Mraised▾
Series A · Bengaluru, Karnataka · founded 2019
Provider of AI-based proteomic data analysis software for drug discovery. The company has designed a computational platform that assists with the analysis and interpretation of various experimental data. The platform uses technology that has features to predict molecular interactions between proteins, prediction of target proteins, and more.
Fliar Intelligence Index™ 69how this company ranks against its industry peers
Growth
top 18%AI
top 23%Talent
top 28%News
top 38%Fin. health
top 42%Funding
top 43%Growth: Revenue +305% YoY · Fresh capital in last 24 mo
AI: Classified as an agentic-AI company · Product described with: ai-based
Talent: 4 named leaders on record · 4 C-suite/founder profiles curated
Audience (LinkedIn): 2k LinkedIn followers
Hiring (LinkedIn): 2 hiring posts in 12 mo (public) · momentum +2 · hiring: Computational Biologist / Chemist, AI / ML Engineer
Funding rounds
- Dec 2025Series A$7.7M
- Aug 2024Angel$112.3K
- Jun 2023Seed$1M
- Nov 2021Angel$337.3K
Founders & team
Investors
Speciale Invest, Tenacity Ventures, BYT Capital, Indian Angel Network Fund, Indian Angel Network, IIT Startups
Tech stack
FirebaseGoogle MapsGoogle WorkspaceHstsHttp/3Open Graph
#12
Acquired · Bengaluru, Karnataka · founded 2000 · 37 employees$12.7Mraised▾
Acquired · Bengaluru, Karnataka · founded 2000 · 37 employees
GangaGen develops novel therapies for the prevention and treatment of bacterial infections, particularly infections that are resistant to antibiotics, through the application of contemporary molecular and clinical sciences. Its lead product is, StaphTAME (Tail Associated Muralytic Enzymes), a proprietary recombinant protein, P128, for the prevention or treatment of Staphylococcal infections is currently in its phase 2 trials. It claims to have capability of killing over 200 strains of S.aureus It also has other products in the pipeline for the treatment of Tuberculosis, Gram-negative infections, C.difficile and E.coli infections
Fliar Intelligence Index™ 27how this company ranks against its industry peers
Product
top 36%Moat
top 39%Growth
top 46%Funding
top 47%Talent
bottom 49%Global
bottom 47%Product: 2 distinct product lines · Company stage: Acquired
Moat: Top 40% by revenue among 42 tracked Infectious Diseases companies · Editorial + unicorn rating 5/10 · IP moat: 16 patents
Growth: Headcount 38 → 37 (-3%) across vintages · Revenue +48% YoY · Web rank 10,000,000 → 50,000,000 YoY
Audience (LinkedIn): 4k LinkedIn followers
Activity (LinkedIn): 1 awards announced in 12 mo
Funding rounds
- Dec 2024Grant (prize money)$7.9M
- Oct 2020Grant (prize money)$2.5M
- Oct 2008Series B$1.8M
- Sep 2006Series B$4.5M
Founders & team
Investors
CARB-X, ATEL Capital Group, Otsuka, ICF, C-CAMP
Tech stack
Animate.CssApache Http ServerBootstrapGoogle Tag ManagerGoogle WorkspaceJquery
Funding & investor landscape
$897.1Mtotal disclosed funding
129companies funded
436disclosed rounds
1rounds last 90 days
Most active investors
Notable founders
Tuhin Bhowmick
Co-Founder & CEO & Director · Pandorum
Arun Chandru
Co-Founder& CTO & Director · Pandorum
Mahesh Pratapneni
Co-Founder & Group CEO · MedGenome
Vedam Ramprasad
Chief Executive Officer (India) · MedGenome
Shantanu
Co-Founder · Kapiva
Anuj Sharma
Co-Founder · Kapiva
Hitesh Goswami
Co-Founder & CEO · 4baseCare
Kshitij Rishi
Co-Founder & COO · 4baseCare
Shyam Vasudevarao
Co-Founder & Director · Forus Health
Chandrasekhar Kuppuswami
Co-Founder & CEO · Forus Health
Shiva Subramanian
Co-Founder & CTO · Biopeak
Rishi Pardal
Co-Founder & CEO · Biopeak
Prism market signals · India · country-scoped Prism corpus, 247,515 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding flat · growth rising
RESEARCH IN BENGALURU · Health & Bio
How research on Biotechnology in Bengaluru is moving
A read on the academic research around Biotechnology in Bengaluru — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 72 papers.
University of Agricultural Sciences and IISc Bangalore lead research on silkworm sericulture, silk biomaterials, and DNA repair, with a cautiously optimistic tone amid recent surge.
72 papers · stance +0.48 · 32% breakthrough · 9% concern
top institutions
- University of Agricultural Sciences, Bangalore24
- Indian Institute of Science Bangalore16
- Bangalore University8
- Indian Institute of Science Education and Research Pune6
- Indian Institute of Science Education and Research Thiruvananthapuram5
leading researchers
Bhavya Nagaraju · D. Chethan · G. Savitha · Ganguly, Akansha · Gautam, Komal · Govinda Kasturappa
prism intelligence · tone & topics
97% positive · 1% critical tone
AgricultureHealthBiologyPharmaceuticalsMedical ResearchGenetics
▲
Breakthroughs18 · 25%
▲ 0%→26% share
0 median citations100% since 2021mostly empirical
Gene research is newly emerging, driving Breakthroughs' field-share from 0% to 26% across 3 papers.
rising sub-themes (early→recent)
- Gene3
- Agriculture2
- Genome2
- Plasmid2
- Histone methylation1
Newly emergingGene 0→3
Landmark Sequence-dependent co-condensation of Lsr2 with DNA elucidates the mechanism of genome compaction in Mycobacterium tu · 1 cites
◆
Advancements34 · 47%
▼ 50%→48% share
▲1.0× share momentum0 median citations97% since 2021mostly empirical
Antimicrobial research newly emerged with 8 papers, anchoring Advancements' sustained 50% field dominance.
rising sub-themes (early→recent)
- Antimicrobial8
- Antimicrobial peptides3
- Immune system3
- Yield (engineering)3
- Agriculture3
Newly emergingAntimicrobial 0→8 · Antimicrobial peptides 0→3 · Immune system 0→3
Landmark Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virus · 893 cites
▼
Concerns5 · 7%
▲ 0%→7% share
0 median citations100% since 2021mostly reviews
Pathosystem, Phosphate, and Effector topics newly emerged, lifting Concerns' field-share from 0% to 7%.
rising sub-themes (early→recent)
- Pathosystem1
- Phosphate1
- Effector1
- Oryza sativa1
- Plant disease resistance1
PATENT MOMENTUM · Bengaluru
Who's building biotechnology IP in Bengaluru
Biocon dominates Bengaluru's biotechnology patents with 690 of 958 filings, while annual activity has cooled from a 2015–2021 plateau toward a declining trend since 2022.
958 patents28 companiespeak 61/yr
filing momentum (YoY)
top patenters
- Biocon690Bengaluru
- Avesthagen87Bengaluru
- String Bio42Bengaluru
- Anthem Biosciences25Bengaluru
- National Centre for Biological Sciences19Bangalore
- GangaGen14Bengaluru
- sami-sabinsa group13Bangalore
- Mynvax9Bengaluru
Common questions
How many Life Sciences companies are there in Bengaluru, India?
Radar tracks 392 indexable Life Sciences companies headquartered in Bengaluru, India, India, that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Bengaluru, India?
The Life Sciences companies in Bengaluru, India on this list have raised a combined $897.1M in disclosed equity funding across 129 funded companies.
Which is the highest-funded Life Sciences company in Bengaluru, India?
MedGenome is the highest-funded Life Sciences company in Bengaluru, India, with $217M in disclosed equity funding.
How many Life Sciences companies in Bengaluru, India are funded?
129 of the 392 Life Sciences companies in Bengaluru, India on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Bengaluru, India?
None of the Life Sciences companies in Bengaluru, India on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Bengaluru, India Life Sciences companies?
The most active investors in Bengaluru, India Life Sciences companies on this list include BIRAC, C-CAMP, Startup Karnataka, Department of Biotechnology, Foundation for Science Innovation and Development.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.